Lundbeck advances Parkinson's research with new Phase 1b data at AD/PD™ 2026
PR Newswire —
Phase 1b data on Lu AF28996, an investigational treatment for people with advanced Parkinson's disease, to be presented at the 2026 AD/PD™ Conference Data evaluated safety, tolerability, pharmacokinetics and early clinical signals of Lu AF28996 Five accepted presentations reflect...